Skip to main content
. 2020 Mar 14;7(9):1903741. doi: 10.1002/advs.201903741

Figure 1.

Figure 1

A scheme of AFT‐PLN@MAp as a targeting anticancer nanoplatform. A potential strategy of AFT‐PLN@MAp is provided for diagnostic and therapeutic treatment of metastasis in lung cancer. Current therapeutic methods intending to cure the metastasis of tumor cells have major issues. This nanoplatform can be used with a MAp to target specific aptamers; PLNs are actively transported to tumor cells. PLNs embedded with AFT target drugs can effectively treat tumor cells, limiting cancer cell metastasis.